Categories
Health

MHRA Approves Nemolizumab for Eczema and Prurigo Nodularis

Source link : https://www.newshealth.biz/health-news/mhra-approves-nemolizumab-for-eczema-and-prurigo-nodularis/

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab (Nemluvio, Galderma) to treat moderate to severe prurigo nodularis in adults and moderate to severe atopic dermatitis in adolescents and adults. The approval covers prurigo nodularis in individuals aged 18 and older. It also includes atopic dermatitis, or eczema, in those […]

Author : News Health

Publish date : 2025-02-18 15:32:29

Copyright for syndicated content belongs to the linked Source.

Exit mobile version

.. . . . . . . . . . . . . . . . . . . . . . . . . %%%. . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - - - - - - - - - - - - - - - - - . . . . .